The NPAR, which combines neutrophil percentage and albumin, is a prognostic factor for patients suffering from various chronic non-communicable diseases such as heart failure, chronic obstructive pulmonary disease, metabolic syndrome, and non-alcoholic fatty liver disease (34, 64–67). Here, ALB is linked to metabolic dysfunction-associated steatotic liver disease.